Trial record 3 of 12 for:    cd101

CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension (STRIVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02734862
Recruitment Status : Recruiting
First Posted : April 12, 2016
Last Update Posted : August 6, 2018
Information provided by (Responsible Party):
Cidara Therapeutics Inc.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 31, 2018
  Estimated Study Completion Date : December 31, 2018